- Home
- PACK vs LYEL Comparison
PACK vs LYEL Comparison
Compare PACK & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PACK | LYEL |
|---|---|---|
| Founded | 1972 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.2M | 490.1M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PACK | LYEL |
|---|---|---|
| Price | $3.83 | $22.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $7.17 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 517.3K | 94.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $395,000,000.00 | $61,000.00 |
| Revenue This Year | $9.47 | N/A |
| Revenue Next Year | $9.54 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.08 | N/A |
| 52 Week Low | $2.91 | $0.39 |
| 52 Week High | $6.31 | $45.00 |
Technical Indicators
Market Signals| Indicator | PACK | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 26.81 | 42.39 |
| Support Level | $3.26 | $21.27 |
| Resistance Level | $6.01 | $27.30 |
| Average True Range (ATR) | 0.34 | 2.05 |
| MACD | -0.15 | -0.01 |
| Stochastic Oscillator | 10.83 | 29.36 |
Price Performance
Historical ComparisonAbout PACK Ranpak Holdings Corp
Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.